Cargando…
Epigenetics and MicroRNAs in Cancer
The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855681/ https://www.ncbi.nlm.nih.gov/pubmed/29401683 http://dx.doi.org/10.3390/ijms19020459 |
_version_ | 1783307153735417856 |
---|---|
author | Ramassone, Alice Pagotto, Sara Veronese, Angelo Visone, Rosa |
author_facet | Ramassone, Alice Pagotto, Sara Veronese, Angelo Visone, Rosa |
author_sort | Ramassone, Alice |
collection | PubMed |
description | The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA complexes that represent the principal actors of the epigenetic phenomena. In this regard, the deregulation of a transcribed non-coding RNA may be both cause and consequence of a cancer-related epigenetic alteration. This review summarizes recent findings that implicate microRNAs in the aberrant epigenetic regulation of cancer cells. |
format | Online Article Text |
id | pubmed-5855681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-58556812018-03-20 Epigenetics and MicroRNAs in Cancer Ramassone, Alice Pagotto, Sara Veronese, Angelo Visone, Rosa Int J Mol Sci Review The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA complexes that represent the principal actors of the epigenetic phenomena. In this regard, the deregulation of a transcribed non-coding RNA may be both cause and consequence of a cancer-related epigenetic alteration. This review summarizes recent findings that implicate microRNAs in the aberrant epigenetic regulation of cancer cells. MDPI 2018-02-03 /pmc/articles/PMC5855681/ /pubmed/29401683 http://dx.doi.org/10.3390/ijms19020459 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ramassone, Alice Pagotto, Sara Veronese, Angelo Visone, Rosa Epigenetics and MicroRNAs in Cancer |
title | Epigenetics and MicroRNAs in Cancer |
title_full | Epigenetics and MicroRNAs in Cancer |
title_fullStr | Epigenetics and MicroRNAs in Cancer |
title_full_unstemmed | Epigenetics and MicroRNAs in Cancer |
title_short | Epigenetics and MicroRNAs in Cancer |
title_sort | epigenetics and micrornas in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855681/ https://www.ncbi.nlm.nih.gov/pubmed/29401683 http://dx.doi.org/10.3390/ijms19020459 |
work_keys_str_mv | AT ramassonealice epigeneticsandmicrornasincancer AT pagottosara epigeneticsandmicrornasincancer AT veroneseangelo epigeneticsandmicrornasincancer AT visonerosa epigeneticsandmicrornasincancer |